Literature DB >> 27270174

Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Tomokazu Souma, Stuart W Tompson, Benjamin R Thomson, Owen M Siggs, Krishnakumar Kizhatil, Shinji Yamaguchi, Liang Feng, Vachiranee Limviphuvadh, Kristina N Whisenhunt, Sebastian Maurer-Stroh, Tammy L Yanovitch, Luba Kalaydjieva, Dimitar N Azmanov, Simone Finzi, Lucia Mauri, Shahrbanou Javadiyan, Emmanuelle Souzeau, Tiger Zhou, Alex W Hewitt, Bethany Kloss, Kathryn P Burdon, David A Mackey, Keri F Allen, Jonathan B Ruddle, Sing-Hui Lim, Steve Rozen, Khanh-Nhat Tran-Viet, Xiaorong Liu, Simon John, Janey L Wiggs, Francesca Pasutto, Jamie E Craig, Jing Jin, Susan E Quaggin, Terri L Young.   

Abstract

Primary congenital glaucoma (PCG) is a devastating eye disease and an important cause of childhood blindness worldwide. In PCG, defects in the anterior chamber aqueous humor outflow structures of the eye result in elevated intraocular pressure (IOP); however, the genes and molecular mechanisms involved in the etiology of these defects have not been fully characterized. Previously, we observed PCG-like phenotypes in transgenic mice that lack functional angiopoietin-TEK signaling. Herein, we identified rare TEK variants in 10 of 189 unrelated PCG families and demonstrated that each mutation results in haploinsufficiency due to protein loss of function. Multiple cellular mechanisms were responsible for the loss of protein function resulting from individual TEK variants, including an absence of normal protein production, protein aggregate formation, enhanced proteasomal degradation, altered subcellular localization, and reduced responsiveness to ligand stimulation. Further, in mice, hemizygosity for Tek led to the formation of severely hypomorphic Schlemm's canal and trabecular meshwork, as well as elevated IOP, demonstrating that anterior chamber vascular development is sensitive to Tek gene dosage and the resulting decrease in angiopoietin-TEK signaling. Collectively, these results identify TEK mutations in patients with PCG that likely underlie disease and are transmitted in an autosomal dominant pattern with variable expressivity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27270174      PMCID: PMC4922711          DOI: 10.1172/JCI85830

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  Aqueous humor dynamics in the aging human eye.

Authors:  C B Toris; M E Yablonski; Y L Wang; C B Camras
Journal:  Am J Ophthalmol       Date:  1999-04       Impact factor: 5.258

2.  Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity.

Authors:  Dae-Young Park; Junyeop Lee; Intae Park; Dongwon Choi; Sunju Lee; Sukhyun Song; Yoonha Hwang; Ki Yong Hong; Yoshikazu Nakaoka; Taija Makinen; Pilhan Kim; Kari Alitalo; Young-Kwon Hong; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

Review 3.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

Authors:  Marie Jeansson; Alexander Gawlik; Gregory Anderson; Chengjin Li; Dontscho Kerjaschki; Mark Henkelman; Susan E Quaggin
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

5.  Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion.

Authors:  J Cameron Millar; Abbot F Clark; Iok-Hou Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-03       Impact factor: 4.799

6.  Axenfeld-Rieger syndrome: further clinical and array delineation of four unrelated patients with a 4q25 microdeletion.

Authors:  Hannah Titheradge; Fiona Togneri; Dominic McMullan; Louise Brueton; Derek Lim; Denise Williams
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

Review 7.  Overview of Cytochrome P450 1B1 gene mutations in patients with primary congenital glaucoma.

Authors:  Ni Li; Yong Zhou; Liang Du; Maoling Wei; Xiaoming Chen
Journal:  Exp Eye Res       Date:  2011-08-16       Impact factor: 3.467

Review 8.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 9.  Primary infantile glaucoma (congenital glaucoma).

Authors:  V P deLuise; D R Anderson
Journal:  Surv Ophthalmol       Date:  1983 Jul-Aug       Impact factor: 6.048

10.  OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy.

Authors:  Jian Han; Angela J Thompson-Lowrey; Alyson Reiss; Vladimir Mayorov; Haomiao Jia; Valerie Biousse; Nancy J Newman; Michael D Brown
Journal:  Genet Med       Date:  2006-04       Impact factor: 8.822

View more
  66 in total

1.  Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.

Authors:  Jason O Moore; Mark A Lemmon; Kathryn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 2.  Vascular heterogeneity and specialization in development and disease.

Authors:  Michael Potente; Taija Mäkinen
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

3.  Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma.

Authors:  Meha Kabra; Wei Zhang; Sonika Rathi; Anil K Mandal; Sirisha Senthil; Goutham Pyatla; Muralidhar Ramappa; Seema Banerjee; Konegari Shekhar; Srinivas Marmamula; Asha L Mettla; Inderjeet Kaur; Rohit C Khanna; Hemant Khanna; Subhabrata Chakrabarti
Journal:  Hum Genet       Date:  2017-06-15       Impact factor: 4.132

Review 4.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

5.  Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels.

Authors:  Yael Kenig-Kozlovsky; Rizaldy P Scott; Tuncer Onay; Isabel Anna Carota; Benjamin R Thomson; Hyea Jin Gil; Veronica Ramirez; Shinji Yamaguchi; Christine E Tanna; Stefan Heinen; Christine Wu; Radu V Stan; Janet D Klein; Jeff M Sands; Guillermo Oliver; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

Review 6.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

7.  Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.

Authors:  Jaeryung Kim; Dae-Young Park; Hosung Bae; Do Young Park; Dongkyu Kim; Choong-Kun Lee; Sukhyun Song; Tae-Young Chung; Dong Hui Lim; Yoshiaki Kubota; Young-Kwon Hong; Yulong He; Hellmut G Augustin; Guillermo Oliver; Gou Young Koh
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

8.  All TIEd up: mechanisms of Schlemm's canal maintenance.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

Review 9.  Angiopoietins and Tie2 in vascular inflammation.

Authors:  Samir M Parikh
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

10.  Identification and functional analysis of an ADAMTSL1 variant associated with a complex phenotype including congenital glaucoma, craniofacial, and other systemic features in a three-generation human pedigree.

Authors:  Kathryn Hendee; Lauren Weiping Wang; Linda M Reis; Gregory M Rice; Suneel S Apte; Elena V Semina
Journal:  Hum Mutat       Date:  2017-08-01       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.